Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 3214Carcinoma, Non-Small-Cell Lung 2727Breast Neoplasms 2550Colorectal Neoplasms 1461Prostatic Neoplasms 1307Neoplasm Metastasis 1300Multiple Myeloma 1112Melanoma 1103Ovarian Neoplasms 1006Lung Neoplasms 944Recurrence 924Leukemia, Myeloid, Acute 879Pancreatic Neoplasms 832Lymphoma, Non-Hodgkin 767Lymphoma 713Stomach Neoplasms 692Carcinoma, Renal Cell 660Carcinoma, Hepatocellular 647Leukemia, Lymphocytic, Chronic, B-Cell 560Squamous Cell Carcinoma of Head and Neck 550Lymphoma, Follicular 515Head and Neck Neoplasms 490Glioblastoma 472Small Cell Lung Carcinoma 447Lymphoma, Large B-Cell, Diffuse 440Triple Negative Breast Neoplasms 435Advanced Solid Tumors 432Leukemia 426Uterine Cervical Neoplasms 420Urinary Bladder Neoplasms 405

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Pregnancy, Ectopic × Clear all
NCT01653392 2024-03-15

BioThrax® (Anthrax) Vaccine in Pregnancy Registry

Emergent BioSolutions

Completed
98 enrolled

Congenital Abnormalities, Abortion, Spontaneous, Birth Weight, Eclampsia, Fetal Death, Hydatidiform Mole, Obstetric Labor, Premature, Pre-Eclampsia, Pregnancy Complications, Pregnancy, Ectopic, Diabetes, Gestational, Premature Birth, Stillbirth, Maternal Death

Data powered by HemOnc (CC BY 4.0) Colophon ⚡